Literature DB >> 19625478

Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 group O infections.

J-C Plantier1, M Djemai, V Lemée, A Reggiani, M Leoz, L Burc, A Vessière, D Rousset, J-D Poveda, C Henquell, A Gautheret-Dejean, F Barin.   

Abstract

Human immunodeficiency viruses (HIV) have a high level of genetic diversity. The outlier variants of HIV type 1 (HIV-1) group O are distantly related to HIV-1 group M. Their divergence has an impact on serological diagnosis, with a risk of false-negative results. In this study, we report 20 failure cases, involving patients with primary or chronic infection, in France and Cameroon between 2001 and 2008. Our results indicate that some assays detected group O infection much less efficiently than others. Two major reasons for these false-negative results were identified: the presence or absence of a group O-specific antigen (and the designed sequence) for the detection of antibodies and the greater envelope variability of group O than of group M strains. This study highlights the complexity of screening for these divergent variants and the need to evaluate test performance with a large panel of strains, due to the extensive diversity of group O variants.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19625478      PMCID: PMC2738113          DOI: 10.1128/JCM.00602-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

Review 1.  Understanding the genetic diversity of HIV-1.

Authors:  F E McCutchan
Journal:  AIDS       Date:  2000       Impact factor: 4.177

2.  Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage.

Authors:  Laurence Vergne; Anke Bourgeois; Eitel Mpoudi-Ngole; Rose Mougnutou; Josephine Mbuagbaw; Florian Liegeois; Christian Laurent; Christelle Butel; Léopold Zekeng; Eric Delaporte; Martine Peeters
Journal:  Virology       Date:  2003-06-05       Impact factor: 3.616

3.  Phylogenetic analysis of 49 newly derived HIV-1 group O strains: high viral diversity but no group M-like subtype structure.

Authors:  P Roques; D L Robertson; S Souquière; F Damond; A Ayouba; I Farfara; C Depienne; E Nerrienet; D Dormont; F Brun-Vézinet; F Simon; P Mauclère
Journal:  Virology       Date:  2002-10-25       Impact factor: 3.616

4.  Isolation of atypical HIV-1-related retrovirus from AIDS patient.

Authors:  H Agut; D Candotti; B Rabanel; J M Huraux; G Remy; D Ingrand; T Tabary; C Chippaux; S Chamaret; D Guetard
Journal:  Lancet       Date:  1992-09-12       Impact factor: 79.321

5.  Plasma RNA quantification and HIV-1 divergent strains.

Authors:  Jean-Christophe Plantier; Marie Gueudin; Florence Damond; Joséphine Braun; Philippe Mauclère; François Simon
Journal:  J Acquir Immune Defic Syndr       Date:  2003-05-01       Impact factor: 3.731

6.  Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate.

Authors:  M Vanden Haesevelde; J L Decourt; R J De Leys; B Vanderborght; G van der Groen; H van Heuverswijn; E Saman
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  Difficulties in diagnosing group o human immunodeficiency virus type 1 acute primary infection.

Authors:  Cécile Henquell; Christine Jacomet; Odile Antoniotti; Abdelhak Chaib; Christel Regagnon; Sylvie Brunet; Hélène Peigue-Lafeuille; Francis Barin
Journal:  J Clin Microbiol       Date:  2008-05-14       Impact factor: 5.948

8.  Subtype B human immunodeficiency virus (HIV) type 1 mutant that escapes detection in a fourth-generation immunoassay for HIV infection.

Authors:  Catherine Gaudy; Alain Moreau; Sylvie Brunet; Jean-Michel Descamps; Pascale Deleplanque; Denys Brand; Francis Barin
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

9.  HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients.

Authors:  I Loussert-Ajaka; T D Ly; M L Chaix; D Ingrand; S Saragosti; A M Couroucé; F Brun-Vézinet; F Simon
Journal:  Lancet       Date:  1994-06-04       Impact factor: 79.321

10.  Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of west-central African origin.

Authors:  R De Leys; B Vanderborght; M Vanden Haesevelde; L Heyndrickx; A van Geel; C Wauters; R Bernaerts; E Saman; P Nijs; B Willems
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

View more
  17 in total

1.  Baseline genotypic and phenotypic susceptibilities of HIV-1 group O to enfuvirtide.

Authors:  Agnès Depatureaux; Charlotte Charpentier; Gilles Collin; Marie Leoz; Diane Descamps; Aurélia Vessière; Florence Damond; Dominique Rousset; Françoise Brun-Vézinet; Jean-Christophe Plantier
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

2.  A Multiplex PCR Approach for Detecting Dual Infections and Recombinants Involving Major HIV Variants.

Authors:  Pierre Cappy; Fabienne De Oliveira; Marie Gueudin; Elodie Alessandri-Gradt; Jean-Christophe Plantier
Journal:  J Clin Microbiol       Date:  2016-02-24       Impact factor: 5.948

3.  Novel Time-Resolved Fluorescence Europium Nanoparticle Immunoassay for Detection of Human Immunodeficiency Virus-1 Group O Viruses Using Microplate and Microchip Platforms.

Authors:  Mohan Kumar Haleyur Giri Setty; Jikun Liu; Prerna Mahtani; Panhe Zhang; Bingchen Du; Viswanath Ragupathy; Krishnakumar Devadas; Indira K Hewlett
Journal:  AIDS Res Hum Retroviruses       Date:  2016-03-15       Impact factor: 2.205

4.  Clinical evaluation of BioPlex 2200 HIV Ag-Ab, an automated screening method providing discrete detection of HIV-1 p24 antigen, HIV-1 antibody, and HIV-2 antibody.

Authors:  Maud Salmona; Severine Delarue; Constance Delaugerre; François Simon; Sarah Maylin
Journal:  J Clin Microbiol       Date:  2013-10-23       Impact factor: 5.948

Review 5.  Non-M variants of human immunodeficiency virus type 1.

Authors:  Thomas Mourez; François Simon; Jean-Christophe Plantier
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

6.  A new real-time quantitative PCR for diagnosis and monitoring of HIV-1 group O infection.

Authors:  Marie Gueudin; Marie Leoz; Véronique Lemée; Fabienne De Oliveira; Aurélia Vessière; Anfumbom Kfutwah; Jean-Christophe Plantier
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

7.  Molecular epidemiology of simian immunodeficiency virus infection in wild-living gorillas.

Authors:  Cécile Neel; Lucie Etienne; Yingying Li; Jun Takehisa; Rebecca S Rudicell; Innocent Ndong Bass; Joseph Moudindo; Aimé Mebenga; Amandine Esteban; Fran Van Heuverswyn; Florian Liegeois; Philip J Kranzusch; Peter D Walsh; Crickette M Sanz; David B Morgan; Jean-Bosco N Ndjango; Jean-Christophe Plantier; Sabrina Locatelli; Mary K Gonder; Fabian H Leendertz; Christophe Boesch; Angelique Todd; Eric Delaporte; Eitel Mpoudi-Ngole; Beatrice H Hahn; Martine Peeters
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

8.  Performance of the Liaison XL Murex HIV Ab/Ag test on clinical samples representing current epidemic HIV variants.

Authors:  Véronique Lemee; Marie Leoz; Manuel Etienne; Fabienne De Oliveira; Jean-Christophe Plantier
Journal:  J Clin Microbiol       Date:  2014-06-25       Impact factor: 5.948

9.  Evaluation of Hologic Aptima HIV-1 Quant Dx Assay on the Panther System on HIV Subtypes.

Authors:  Mark M Manak; Holly R Hack; Sangeetha V Nair; Andrew Worlock; Jennifer A Malia; Sheila A Peel; Linda L Jagodzinski
Journal:  J Clin Microbiol       Date:  2016-08-10       Impact factor: 5.948

10.  Performance of the BioPlex 2200 HIV Ag-Ab assay for identifying acute HIV infection.

Authors:  Susan H Eshleman; Estelle Piwowar-Manning; Mariya V Sivay; Barbara Debevec; Stephanie Veater; Laura McKinstry; Linda-Gail Bekker; Sharon Mannheimer; Robert M Grant; Margaret A Chesney; Thomas J Coates; Beryl A Koblin; Jessica M Fogel
Journal:  J Clin Virol       Date:  2018-01-11       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.